Literature DB >> 15000285

Combined carcinoid-adenocarcinoma tumour of the anal canal.

G K Anagnostopoulos1, D Arvanitidis, G Sakorafas, G Pavlakis, L Kolilekas, E Arkoumani, D Stefanou.   

Abstract

The concurrence of carcinoid admixed with adenocarcinoma in the gastrointestinal tract is an unusual phenomenon that has been reported in the oesophagus, stomach, small intestine, appendix, colon and rectum. These mixed or 'composite' tumours seem to be derived from a multipotential stem cell capable of bidirectional differentiation and have a worse prognosis than ordinary adenocarcinoma. Chromogranin-A staining has increased the diagnostic yield for detecting these tumours and provides information for perioperative management and long-term prognosis. We describe a patient who presented to our department due to painful defecation. Sigmoidoscopy demonstrated a mass in the anal canal. Histology revealed that the tumour was a mixed carcinoid-adenocarcinoma neoplasm. To our knowledge, this is the first report in the English literature of a composite tumour of the anal canal.

Entities:  

Mesh:

Year:  2004        PMID: 15000285     DOI: 10.1080/00365520310007125

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Early precursor of mixed endocrine-exocrine tumors of the gastrointestinal tract: histologic and molecular correlations.

Authors:  Fateh Bazerbachi; Taher R Kermanshahi; Carmela Monteiro
Journal:  Ochsner J       Date:  2015

2.  Composite adenocarcinoma and large cell neuroendocrine carcinoma of the rectum.

Authors:  A Makino; S Serra; R Chetty
Journal:  Virchows Arch       Date:  2006-03-01       Impact factor: 4.064

3.  Perianal Goblet Cell Carcinoid With Pagetoid Spread.

Authors:  Dianne Grunes; Michelle Kang Kim; David B Chessin; Rona D Yaeger; Stephen C Ward
Journal:  Int J Surg Pathol       Date:  2019-05-13       Impact factor: 1.271

4.  Composite neuroendocrine tumor and adenocarcinoma of the rectum.

Authors:  Hiromi Kanno-Okada; Tomoko Mitsuhashi; Katsuhiro Mabe; Tadakazu Shimoda; Yoshihiro Matsuno
Journal:  Diagn Pathol       Date:  2017-12-11       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.